Skip to main content
Log in

Bismuth subsalicylate suppression ofHelicobacter pylori in nonulcer dyspepsia: A double-blind placebo-controlled trial

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Gastritis caused byHelicobacter pylori (HP) is common in patients with nonulcer dyspepsia (NUD), but an etiologic relationship between the histologic lesion and clinical symptoms is unproven. HP is inhibited by bismuth subsalicylate (BSS), a traditional remedy for dyspeptic complaints. The aim of this study was to assess the short- and long-term effects of BSS on HP, gastritis, and symptoms in patients with NUD. One hundred twenty-six patients with NUD who were shown to be infected withH. pylori (HP+) were enrolled. There was a two-week placebo run-in period to eliminate placebo responders. Fifty patients remained symptomatic and were randomly assigned to therapy with either BSS liquid or a matching placebo. EGD, biopsy, and clinical evaluations were performed at entry, at week 5 (end of therapy), at week 9 (four weeks after therapy), or at time of symptomatic relapse. Twenty-seven patients received placebo and 23 patients received BSS. BSS suppressedH. pylori in 15/23 patients (65%) and eradicated it in one patient, whereas the placebo had no effect onH. pylori. Gastritis improved during therapy with BSS but relapsed by week 9. There was no significant change in level of dyspeptic symptoms during or after treatment, although one month after the end of treatment, the patients in the BSS group consistently had lower symptom scores and fewer symptomatic days for all symptoms measured. The study confirms that BSS given for three weeks suppresses but does not usually eradicateH. pylori. Such short-term suppression ofH. pylori heals gastritis but does not result in clinical improvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Barbara L, Camilleri M, Corinaldesi R Crean GP, Heading RC, Johnson AG, Malagelada JR, Stanghellini V, Wienbeck M: Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci 34(8):1272–1276, 1989

    Google Scholar 

  2. Colin Jones DG:Campylobacter pylori. An advance in understanding of dyspepsia and gastritis. J Clin Gastroenterol 11:S39-S42, 1989

    Google Scholar 

  3. Talley NJ, Phillips SF: Non-ulcer dyspepsia: Potential causes and pathophysiology. Ann Intern Med 108(6):865–879, 1988

    Google Scholar 

  4. Pettross CW, Appleman MD, Cohen H, Valenzuela JE, Chandrasoma P, Laine LA: Prevalence ofCampylobacter pylori and association with antral mucosal histology in subjects with and without upper gastrointestinal symptoms. Dig Dis Sci 33:649–653, 1988

    Google Scholar 

  5. Rokkas T, Pursey C, Uzoechina E, et al:Campylobacter pylori and non-ulcer dyspepsia. Am J Gastroenterol 82:1149–1152, 1987

    Google Scholar 

  6. Kang JY, Wee A, Math MV et al:Helicobacter pylori and gastritis in patients with peptic ulcer and non-ulcer dyspepsia: Ethnic differences in Singapore. Gut 31:850–853, 1990

    Google Scholar 

  7. Strauss RM, Wang TC, Kelsey PB et al: Association ofHelicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy. Am J Med 89:464–469, 1990

    Google Scholar 

  8. Dye KR, Marshall BJ, Frierson HF, Barrett LJ, Guerrant RL, McCallum RW: Is CLOtest alone adequate to diagnoseCampylobacter pylori? Am J Gastroenterol 83:1032, 1988 (abstract)

    Google Scholar 

  9. Gad A, Dobrilla G:Campylobacter pylori and non-ulcer dyspepsia. 1. The final results of a double-blind multicentre trial for treatment with pirenzepine in Italy. Scand J Gastroenterol Suppl 167:39–43, 1989

    Google Scholar 

  10. Britt DP, Barakat MH, Tungekar MF, et al: Helicobacter pylori in dyspeptic patients in Kuwait. J Clin Pathol 43:987–991, 1990

    Google Scholar 

  11. Tytgat GN, Rauws EA, De Koster E:Campylobacter pylori. Scand J Gastroenterol Suppl 155:68–81, 1988

    Google Scholar 

  12. Marshall BJ: Should we now, routinely, be examining gastric biopsies forCampylobacter pylori? Gastric mucosal biopsy: An essential investigation in patients with dyspepsia. Am J Gastroenterol 83:479–481, 1988

    Google Scholar 

  13. Marshall BJ, Armstrong JA, Francis GJ, Nokes NT, Wee SH: The antibacterial action of bismuth in relation toCampylobacter pyloridis colonization and gastritis. Digestion 37(suppl 2):16–30, 1987

    Google Scholar 

  14. Talley NJ:Campylobacter pylori-associated gastritis. Is antibiotic therapy now justified. J Clin Gastroenterol 10:10–12, 1988

    Google Scholar 

  15. Dooley CP, Cohen H: The clinical significance ofCampylobacter pylori. Ann Intern Med 108:70–79, 1988

    Google Scholar 

  16. Lanza FL, Skoglund ML, Rack MF, Yardley JH: The effect of bismuth subsalicylate on the histologic gastritis seen withCampylobacter pylori: A placebo-controlled, randomized study. Am J Gastroenterol 84:1060–1064, 1989

    Google Scholar 

  17. McNulty CA: Bismuth subsalicylate in the treatment of gastritis due toCampylobacter pylori. Rev Infect Dis 12:S94-S98, 1990

    Google Scholar 

  18. Marshall BJ, Warren JR, Francis GJ, Langton SR, Goodwin CS, Blincow E: Rapid urease test in the management ofCampylobacter pyloridis-associated gastritis. Am J Gastroenterol 82(3):200–210, 1987

    Google Scholar 

  19. McNulty CA, Gearty JC, Crump B, et al:Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. Br Med J (Clin Res) 293:645–649, 1986

    Google Scholar 

  20. Rokkas T, Pursey C, Uzoechina E, et al: Non-ulcer dyspepsia and short term De-Nol therapy: A placebo controlled trial with particular reference to the role ofCampylobacter pylori. Gut 29:1386–1391, 1988

    Google Scholar 

  21. Lambert JR, Dunn K, Borromeo M, Korman MG, Hansky J:Campylobacter pylori—a role in non-ulcer dyspepsia. Scand J Gastroenterol Suppl 160:7–13, 1989

    Google Scholar 

  22. Kang JY, Tay HH, Wee A, Guan R, Math MV, Yap I: Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study. Gut 31:476–480, 1990

    Google Scholar 

  23. Loffeld RJ, Potters HV, Stobberingh E, Flendrig JA, van Spreeuwel JP, Arends JW: Campylobacter associated gastritis in patients with non-ulcer dyspepsia: A double blind placebo controlled trial with colloidal bismuth subcitrate. Gut 30:1206–1212, 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marshall, B.J., Valenzuela, J.E., McCallum, R.W. et al. Bismuth subsalicylate suppression ofHelicobacter pylori in nonulcer dyspepsia: A double-blind placebo-controlled trial. Digest Dis Sci 38, 1674–1680 (1993). https://doi.org/10.1007/BF01303177

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01303177

Keywords

Navigation